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Purpose. Adequate calcium intake is the basis of osteoporosis therapy—when this proves insufficient, even specific antiosteoporotic
agents cannot exert their actions properly.Methods. Our representative survey analyzed the dietary intake and supplementation of
calcium in 8033 Hungarian female and male (mean age: 68 years) (68.01 (CI95: 67.81–68.21)) patients with osteoporosis. Results.
Mean intake from dietary sources was 665 ± 7.9mg (68.01 (CI95: 67.81–68.21)) daily. A significant positive relationship could
be detected between total dietary calcium intake and lumbar spine BMD (𝑃 = 0.045), whereas such correlation could not be
demonstrated with femoral 𝑇-score. Milk consumption positively correlated with femur (𝑃 = 0.041), but not with lumbar BMD.
The ingestion of one liter of milk daily increased the 𝑇-score by 0.133. Average intake from supplementation was 558 ± 6.2mg
(68.01 (CI95: 67.81–68.21)) daily.The cumulative dose of calcium—fromboth dietary intake and supplementation—was significantly
associated with lumbar (𝑟 = 0.024, 𝑃 = 0.049), but not with femur BMD (𝑟 = 0.021, 𝑃 = 0.107).The currently recommended 1000–
1500mg total daily calcium intake was achieved in 34.5% of patients only. It was lower than recommended in 47.8% of the cases
and substantially higher in 17.7% of subjects. Conclusions. We conclude that calcium intake in Hungarian osteoporotic patients is
much lower than the current recommendation, while routinely applied calcium supplementation will result in inappropriately high
calcium intake in numerous patients.
1. Introduction
As suggested by abundant data, calcium supplementation by
itself—although to a modest extent only—can decrease bone
loss, and thereby increase bone mineral density (BMD) in
osteoporotic patients [1]. According to evidence from the
Cochrane database, at least two years of calcium supple-
mentation will result in a BMD increase of 1.66% in the
lumbar spine, 1.60% in the hip region, and 1.91% in the
distal radius, respectively [2]. However, for the prevention of
osteoporotic fractures, calcium supplementation is effective
only in combination with vitamin D, although there are data
available to refute the importance of this intervention [3].
The Decaylos I study, conducted on 3270 elderly French
women, aged 84 years on average, evaluated the role of
concomitantly administered calcium and vitaminD in reduc-
ing fracture risk [4]. The subjects received 1200mg calcium
with 800 IU vitamin D or placebo daily, over three years.
By the end of the third year, the number of hip fractures,
as well as of all nonvertebral fractures decreased by 29%
and 24%, respectively. In a Danish study [5] of 9605 elderly
patients, combination therapy with 1000mg calcium and
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800 IU vitamin D daily reduced the number of fractures
significantly, by 27%.These findings were confirmed by Tang
et al. [6]. In their meta-analysis of 29 trials conducted on
64,000 individuals over the age of 50 years, calcium supple-
mentation was associated with a 12% reduction of the total
number of fractures.
Nevertheless, contradicting results have also been report-
ed. In aDutch study of 2578women [7],mean dietary calcium
intake, which was considered high (868mg/day on average),
was supplemented with 400 IU/day vitamin D for 3.5 years,
but even this failed to mitigate fracture risk. In the secondary
prevention RECORD study [8], 5292 osteoporotic patients
aged over 70 years and with prevalent fractures received 1000
mg calcium with 800 IU vitamin D daily, or placebo. This
regimen failed to achieve any significant reduction of fracture
risk in the treatment groups. However, only 60% of the sub-
jects were compliant to the therapy (who have taken their
study medications according to the intended dosage), which
seriously challenges the validity of this finding.
Currently, supplementation with vitamin D and calcium
should be regarded as the basic therapy of osteoporosis [9,
10]. In osteoporotic patients, the daily intake of at least 800
to 1000 IU vitamin D and of 1000 to 1500mg calcium is
necessary to increase BMDand to reduce fracture risk [11, 12].
Although calcium and vitamin D are similarly effective
whether they are from dietary sources or from supplementa-
tion; international andHungarian data suggest that the intake
of both needs an—occasionally substantial—increase [13].
Other potential explanations for the study findings, seem-
ingly challenging the effectiveness of calcium and vitamin D
replacement, include the use of nonstandard methods for
estimating the daily intake of subjects, and supplementation
with various calcium preparations, which produced differing
increases of serum calcium levels [14]. Together, these might
sometimes have led to suboptimal efficacy of the daily supple-
mentation with calcium and vitamin D.
The aim of our study was to appraise the dietary intake
as well as the supplementation of calcium in osteoporotic
patients in Hungary.
2. Material and Methods
2.1. Participants and Study Protocol. We conducted a survey
using a validated questionnaire (source: modified from
Groupe de Recherche et d’Information sur les Oste´oporoses,
http://www.grio.org/calcul-apport-calcique-quotidien.php)
[15], completed by medical professionals at the osteoporosis
centers, following an interview with study subjects. One
hundred and eighty-one physicians of 110 study sites, evenly
distributed over Hungary, co-operated in this survey. The
completed questionnaires accumulated information on
osteoporotic 9215 patients.
The questionnaires were dispensed in batches of fifty, in
a form similar to that of copybooks comprising sheets with
preprinted serial numbers. Using simple questions (most of
which required a numerical entry as a response only), the
questionnaire attempted to estimate the intake of calcium-
containing foods over a given period (The questionnaire
(amended version)).These responses were then used to gauge
daily calcium intake based on the frequency of ingestions and
of the known calcium content of individual foodstuffs. Addi-
tional questions, pertaining to calcium supplementation with
medicinal products, served to determine daily intake from
this source. The severity of osteoporosis was characterized
by bone density measured on the total femur and the lumbar
(L
2–4) spine (BMD was expressed as g/cm
2 and as 𝑇-score).
Bone mineral density was measured at the total femur and
at the lumbar spine by dual X-ray absorptiometry by Lunar
Prodigy (GE Medical Systems, Diegem, Belgium), Norland
pDEXA (CooperSurgical Inc., Trumbull, CT, USA), and
Hologic QDR 4500 (Hologic Inc., Bedford, MA, USA). Coef-
ficient of variation was below 1% at both sites. Osteoporosis
was defined according to the WHO criteria, as a 𝑇-score less
than −2.5 at any measured site.
The questionnaire (amended version)
Serial N∘:
Ca-intake.hu Study
version 2.0 of the questionnaire for the appraisal of daily calci-
um intake in osteoporotic patients
Gender: female/male
Patient’s initials:
Age:
Date of birth:
Body weight:
Body height:
(Please do measure the weight/height of the
patient!)
Lumbar 𝑇-score:
Region: L
1−5
/L
2−4
/L
2−5
Femoral 𝑇-score:
Densitometer make & model:
Antiosteoporotic agent:
Dosage:
Daily/Weekly/Monthly/Every 3months/Annually
Vitamin D supplementation:
tablets/capsules/solution
Dosage: x Daily/Weekly/Other
Calcium supplementation: Yes/No
If yes, tablets.
Dosage: x tablets daily.
OTC preparation? Yes/No
If POM:
Is it prescribed by a specialist? Yes/No
Is it prescribed by the family practitioner?
Yes/No
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(1) Do you drink milk every day?
If yes, how many glasses (2 deciliters)?
If not every day, then how many glasses of milk
do you drink per week?
(2) Do you eat yogurt, kefir, or curd?
If yes, then howmany servings of 100mL do you
eat per week?
(3) Do you eat sour cream?
If yes, then howmany servings of 100mL do you
eat per week?
(4) How much bread do you eat daily?
Whole slice: . . . pieces
(5) How much pasta do you eat per week?
⋅ ⋅ ⋅ × 100-g servings
(6) How much meat do you eat per week?
(a) chicken (100-g servings): . . ./week
(b) pork (100-g servings): . . ./week
(c) Parisian/saveloy sausages (100-g servings):
. . ./week
(7) Do you eat canned fish in oil?
If yes, how many cans per week?
(8) How much vegetable do you eat per week?
(300-g servings)
(a) spinach, sorrel: . . . servings
(b) green peas, kale, French beans: . . . servings
(9) Do you eat cheese regularly?
If yes, howmany 20-g servings per week (see the
photo)?
(10) How much potato do you eat per week?
⋅ ⋅ ⋅ × 100-g servings
(11) How many eggs do you eat per week?
(12) How many medium-sized apples do you eat per week?
(13) How many glasses (200-mL) of mineral water do you
drink daily?
(a) branded products: Szentkira´lyi, Natur Aqua
(b) branded products: Theodora Quelle, Margit-
szigeti, Visegra´di
(c) other unbranded mineral water:
How long have you been adhering to these eating
habits?
(a) all my life
(b) for . . . years
If you have changed your diet long ago, you had done
this on:
(a) advice from your doctor
(b) other advice
TO BE COMPLETED BY THE INVESTIGATOR!
Calcium content of the daily menu:
(1) . . .
(2) . . .
(3) . . .
(4) . . .
(5) . . .
(6.a) . . .
(6.b) . . .
(6.c) . . .
(7) . . .
(8.a) . . .
(8.b) . . .
(9) . . .
(10) . . .
(11) . . .
(12) . . .
(13.a) . . .
(13.b) . . .
(13.c) . . .
Daily calcium intake:
Questionnaires from 8033 of the 9215 surveyed osteo-
porotic patients were complete and thus suitable for evalua-
tion. This means that considering the approximately 330,000
patients (including treated anduntreated ones, ESKI, 2009) as
reckoned by the collaborating study sites, population cov-
erage exceeded 2.5% altogether. Within the evaluated pop-
ulation (𝑛 = 8033), the proportion of males was 7.1% (𝑛 =
569) compared to the dominant 92.9% share of females (𝑛 =
7464). Mean age of the subjects was 68 years (range 41 to
98). The age distribution of the study population was similar
to that exhibited by the national age distribution chart, even
for males and females analyzed separately. The body mass
index (BMI)was normal in 38.8%of participants (BMI= 18.5-
24.9 kg/m2); the proportion of underweight subjects was
6.2% (BMI< 18.5 kg/m2), whereas 55.0% were overweight
(BMI= 25.0–29.9 kg/m2) or obese (≥30 kg/m2).Mean lumbar
and femoral 𝑇-scores were −2.836 ± 0.03 and −2.434 ± 0.03,
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Table 1: The baseline characteristics of our patients.
Gender (%)
Male = 569 (7.1)
Female = 7464 (92.9)
Total = 8033 (100)
Age (years) 41–98Mean: 68.01
Lumbar 𝑇-score −9.37–1.5Mean: −2.836 ± 0.03
Femoral 𝑇-score −8.66–0.9Mean: −2.434 ± 0.03
Weight (kg) 32–130Mean: 66.78
Height (cm) 120–194Mean: 159.93
BMI (kg/m2) 13.62–60.26Mean: 26.11
Vitamin D supplementation (%)
𝑛 = 5773 (71.7)
Calcium supplementation (%)
𝑛 = 5813 (72.6)
Mean dietary calcium intake (mg) 665 ± 7.9Female = 599 ± 22.7
Male = 673 ± 8.4
respectively. Lumbar and femoral BMD values were related
also to age (Table 1).
We did not impose quotas on the selection of responders,
in order to accomplish the widest possible population cover-
age. The course of the survey had two stages, during which
a slightly different (amended) version of the same ques-
tionnaire was used. Modification was necessary because the
original version contained ambiguous questions on cheese
consumption. Specifically, 50 gramswere defined as a serving,
but this proved excessive, resulting in unrealistically high
cheese consumption; this was changed to 20 grams in the
second version. Additionally, the first version contained two
questions on two cheese categories. In the second version, this
was reduced to a single, comprehensive question not dis-
tinguishing between different types of cheese. Finally, the
question on meat consumption reckoned with daily intake in
the original version. All these changes had no influence on the
standardized analysis of results.
2.2. Statistics. The initial step of data processing consisted
of digitizing the questionnaires, performing the digitally
assisted recording of data in duplicate, and finally, cor-
recting errors. Handwritten notes modifying the frequency
entries made on the questionnaires were also recorded (e.g.,
when the investigator invalidated the “daily” specification
by striking it through and entered “weekly” in replacement
before completing the entry on bread consumption). Error
correction involved checking for records containing logical
inconsistencies, outlier values, and skipped entries.Question-
naires containing uncorrectable errors were excluded from
the analysis along with those that were deemed unusable
for other reasons. The latter included duplicates (identified
by matching patient’s initials, date of birth, and gender on
questionnaires from the same or from a nearby study site);
sheets without the age or gender of the subject (if retrieving
these data was not feasible, for example, owing to the absence
of the date of birth or the information on marital status).
Sheets containing data from subjects without osteoporosis
(as evidenced by 𝑇-scores of the lumbar spine and of the
femur) were also discarded. As no selection quotas were
imposed during the survey, weighing was used to ensure
the representativeness of the sample. This was necessary,
because the proportions of patients included in the individual
counties were at variancewith nationwide data on patient dis-
tribution. For example, the proportion of patient data accu-
mulated from Tolna County was larger than that obtained
from Vas County, whereas national data show a different
distribution. Therefore, the results from both counties were
corrected with an appropriate multiplier—using a method
known as element number stabilization weighing, to obtain
results matching their nationwide weights. We recruited
the entire Hungarian population of osteoporotic patients as
reference (data source: National Institute for Quality and
Organizational Development in Healthcare and Medicine—
Informatics and System Analysis Directorate/ESKI/, 2009).
It is defined as the total number of individuals (specified
according to county, age, and gender) receiving in-/outpatient
care within the Hungarian health care system, as well as
any form of osteoporosis is specified in their primary care
reports as an underlying or accompanying disorder. Patients
were reckoned by using the data on their age and residence
(by county), as recorded at the first presentation during the
actual year. The numbers of patients per counties and male-
to-female ratios were approximated to the national average.
As—among others—age was taken into account during
weighing, thismethodwe consider element number stabiliza-
tion weighing for three dimensions (age, gender, and region).
During the calculations, in the knowledge of the calcium
content of selected foodstuffs, we performed the multiplica-
tion corresponding with the given frequency period to obtain
per patient calcium intake in total and for each foodstuff.Data
accumulated with the two versions of the questionnaire were
pooled, in order to increase sample size. As regards to the
original version of the questionnaire, calcium intake calcu-
lated from responses to the question on cheese consumption
was 2.5 times higher than that reckoned from the entries of
the corresponding item of the amended version. Considering
the amendment of the original version after the preliminary
analysis (changes included attaching a photomake estimating
the quantity of consumed cheese easier), we implemented the
following correction. Calcium intake from cheese consump-
tion, as estimated with the original version, was adjusted with
the quotient of the means determined with both versions.
These data on dietary calcium intakewere used to exclude
unrealistically low or high values, and the same procedure
was then performed on calcium supplementation data. Dis-
ease severity and the appropriateness and efficacy of the diet
and medication were compared with each other, as well as
by regions. No sample size calculation was performed prior
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to conduct of the study. For the data analysis, we performed
ANOVA tests and linear regression models, respectively. The
significance level (alpha) was used 0.05. The given values at
the numeric results are the 95% confidence intervals (CI)
of the results. The analyses were performed using the SPSS
(SPSS Inc., Chicago, IL, USA) software package (IBM SPSS
Statistics 20.0.0).
3. Results
Of the 8033 evaluated osteoporotic subjects, 5733 (71.7%)
received vitamin D supplementation with a mean dose of
756±8.8 IU (68.01 [CI95: 67.81–68.21]), which is essentially in
agreement with the recommendations of current professional
protocols.Hydroxylated vitaminDwas administered to 13.3%
of patients. We did not detect any relationship between
vitamin D supplementation and BMD values.
The mean dietary calcium intake was 665 ± 7.9mg (68.01
[CI95: 67.81–68.21]). It was influenced by several factors.
These include gender, as the daily intake was significantly
lower inmales than in females−599±22.7 versus 673±8.4mg
(68.01 [CI95: 67.81–68.21]) (𝑃 < 0.001). Additional influenc-
ing factors included the presence as well as the volume ofmilk
consumption (Figure 1). The higher was the daily milk con-
sumption, the greater became dietary calcium intake. Using
this parameter, we assigned the study population into the
following four subsets: (1) patients abstaining from milk,
(2) subjects with low consumption (less than one glass—
200mL—of milk per week), (3) moderate consumption (less
than a half glass—100mL—ofmilk a day), or (4) regular milk
drinkers (more than a half glass—100mL—ofmilk daily).The
proportions of subjects in these categories were 20.1%, 3.8%,
12.5%, and 63.6%, respectively. According to this stratifica-
tion, dietary calcium intake was significantly (𝑃 < 0.001)
greater in regular milk drinkers than in other subjects. The
daily intake of calcium from dietary source was not related to
BMI.
𝑇-scores correlated with dietary calcium intake, accord-
ing to a multiple relationship. The quantity of calcium from
food sources was not related to the BMD of the femur (𝑃 >
0.1), whereas a positive correlation could be demonstrated
with lumbar𝑇-score (𝑃 = 0.045). Analyzing BMDexclusively
from the aspect of milk consumption, a positive correlation
could be shown with femoral BMD, but not for lumbar BMD
(Figure 2). In other words, a daily milk consumption of one
liter (providing 1200mg calcium) increased the𝑇-score of the
total femur by 0.133.
Of the 8033 subjects, 5813 received some form of cal-
cium supplementation, which proved adequate for 72.6%.
The mean daily dose of the supplemented calcium was
558 ± 6.2mg. Analysis by age did not reveal any significant
difference, whereas comparison by gender did: it was on
average 560± 6.6mg (68.01 (CI95: 67.81–68.21)) in females
and significantly smaller 534 ± 18.9mg (68.01 (CI95: 67.81–
68.21)) in males (𝑃 = 0.012).
The cumulative dose of calcium from dietary intake and
from supplementation was significantly related to lumbar
BMD (𝑟 = 0.024, 𝑃 = 0.049), while no relationship could
be detected with femoral BMD (𝑟 = 0.021, 𝑃 = 0.107).
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Figure 1:The relationship between the volume ofmilk consumption
and daily calcium intake (𝑃 < 0.001): the higher was the daily milk
consumption, the greater became dietary calcium intake. Note. Low
milk consumption: never or less than a glass (two deciliters) of milk
per week (rare); moderate milk consumption: less than half a glass
(one deciliter) of milk a day; regular milk drinkers: more than half
a glass (one deciliter) of milk daily. ∗∗∗𝑃 < 0.001 versus abstainers
and subjects with low or moderate milk consumption.
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Figure 2: The relationship between the presence of milk consump-
tion and the 𝑇-score of the femur (𝑃 = 0.041).
Figure 3 illustrates calcium supplementation in relation to
dietary calcium intake.The recommended daily allowance of
1000 to 1500mg calcium was fulfilled in as low as 34.5% of
treated patients only. In the majority of osteoporotic patients,
total daily calcium intake was below this target or exceeded it
substantially.
4. Discussion
The Ca-Intake.hu study was the first Hungarian project to
evaluate daily calcium intake in osteoporotic patients. Earlier,
only Biro´ et al. have published data on Hungarian healthy
adolescents [16]. According to their findings, daily calcium
intake is as low as 800mg in boys and 700mg in girls. In
France, for example, it is 754mg—that is, half of the rec-
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Figure 3:The relationship between calcium intake from supplemen-
tation and from dietary sources. Note. The recommended RDA of
1000 to 1500mg total calcium intake is met in approximately 34.5%
of patients only. In themajority of subjects, total daily calcium intake
is either below or above the recommended range.
ommended RDA—among urban dweller women with post-
menopausal osteoporosis [17]. Our analysis of dietary cal-
cium intake inmore than 8000 patients, which is an outstand-
ingly large population even in international comparison, has
supplied evidence confirming that calcium intake among
osteoporotic patients in Hungary is even lower than most of
the published data.
Additionally, the Ca-Intake.hu study supplied informa-
tion on average daily calcium intake from supplements,
which was 558mg. In view of the dietary intake, this amount
of calcium results in an adequate total calcium intake in the
lesser proportion (34.5%) of patients only, and it is below or
well above the recommended in the majority of osteoporotic
patients. This finding is probably a consequence of routinely
handled calcium supplementation doses. This practice can
be seen even in clinical pharmacology trials conducted in
osteoporosis. The study protocol only rarely prescribes the
appraisal of calcium intake along with the consequential
adjustment of supplementation. Not withstanding the con-
flicting data, 1000 to 1500mg/day calcium and 800 to 1000 IU
vitamin D in combination are likely to increase bone mass
andmitigate fracture risk effectively [18–21]. Actually, subop-
timal dosing with calcium could be a potential explanation
for the findings from the international studies that failed to
demonstrate the beneficial effect of calcium and vitamin D
supplementation either on bone mass or on of fracture pre-
vention. In theRECORDstudy [8], the unfavorable results are
attributable to poor patient compliance; however, the under-
dosing of calcium supplementation is just as deleterious.
Moreover, it should be kept in mind that excessive calcium
intake can increase the number of bone fractures [22] as well
as the incidence of prostate cancer in males [23].
In our study, milk consumption correlated with BMD of
the total femur, whereas calcium from other foods or total
daily calcium intake had no such relationship. The opposite
holds true for the bone density of lumbar vertebraewhichwas
not related to milk consumption but showed a positive cor-
relation with the cumulative dose of calcium from dietary
intake and from supplementation. Others reported contrary
findings in adolescents: bone densitometry of the lumbar
spine (without appraisal of the femur) showed a significant
relationship (mediated by insulin-like growth factor 1/IGF-1/)
between BMD and milk consumption, but not with calcium
from other dietary sources [24]. Potential explanations for
these findings include the concomitant intake of additional
nutrients (such as magnesium) and proteins present in milk.
IGF-1, as well as milk proteins have been shown to exert
an anabolic effect on bone. IGF-1 increases the number and
enhances the activity of osteoblasts, while stimulating colla-
gen synthesis by these cells [25]. The beneficial effect of milk
consumption as well as of treatment with the extract of the
milk basic protein fraction on bone turnover (both in cortical
and in trabecular substance) in adolescents as well as in adult
or elderly women have been reported by others [24, 26, 27]—
although contradicting data also exist [28]. The STRAMBO
study, for example, showed in males under the age of 65 a
harmful effect of a daily calcium intake less than 600mg both
on cortical and on trabecular bone [29].
Our study also has several limitations. The study results
inherited a limitation from the questionnaire distribution.
At the beginning of the study, no sample size calculation was
made, so this resulted in an unbalanced distribution of
patient numbers from each Hungarian region. Though these
limitations apply, the relatively high sample size strengthens
the power of the study.The questionnaire design itself leads to
concerns about our results. Data entry and cleaning efforts
had been made to identify and clean the strike throughs of
weekly/daily frequencies. The one-time questionnaire
method should be replaced by digital questionnaire or a
week-long food and drink logging in the future to avoid
biases resulting from the patient’s situation being interviewed
personally by their physician. Another limitation is caused
by the exact definition of food quantities for that we have to
define more robust method to ensure that all patients
understand the objective food amounts. Strait methods of
measuring calcium intake via water and other drinks should
also be determined for the future. In conclusion, these
limitations do not affect our main finding about the
inappropriate methodology in the field of calcium supple-
mentation.
As confirmed by the Ca-Intake.hu study, the bone density
of lumbar vertebrae positively correlated with the total daily
intake of calcium from food and from supplementation. Boo-
nen et al. [18] processed the results of six randomized clinical
studies involving 45,000 patients and found an 18% reduction
of hip fractureswith calciumand vitaminD supplementation.
The ICARO study [30] was the first to demonstrate that the
lack of compliance with calcium and vitamin D regimens
reduces the antifracture efficacy of antiosteoporotic therapies,
compared to that seen in controlled studies (and in combina-
tion with adequate calcium and vitamin D supplementation).
Thus, any of the tested antiosteoporotic agents can achieve its
maximum effect only in the presence of calcium and vitamin
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D sufficiency. According to the findings of the Ca-Intake.hu
study, the level of vitamin D supplementation in Hungary
is on par with that recommended by current international
guidelines.
5. Conclusion
In conclusion, calcium intake in Hungarian osteoporotic
patients is much lower than the current recommendation,
while routinely applied calcium supplementation will result
in inappropriately high calcium intake in numerous patients.
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